CClinicalTrials.gg
CompletedNCT05399628Updated Jul 26, 2022

LISA Catheter With Marked vs. Unmarked Tip in Extremely Low Birth Weight Infants With RDS

An interventional study of Surfactant administration with less invasive surfactant administration (LISA) marked tip catheter and Surfactant administration with less invasive surfactant administration (LISA) unmarked tip catheter in Respiratory Distress Syndrome, Newborn, sponsored by University Hospital Padova. Completed at 1 site in Italy. Per ClinicalTrials.gov, last updated 2022-07-26.

Sponsored by University Hospital Padova · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Sex
All
01

Study summary

This is an unblinded, randomized, controlled, crossover (AB/BA) trial of surfactant treatment with LISA catheter with a marked tip vs. LISA catheter with an unmarked tip in a manikin simulating an extremely low birth weight infant. Participants will be level III NICU consultants and residents. Randomization will be performed using a computer-generated random assignment list. The primary outcome measure will be the positioning of the device at the correct depth in the trachea. The secondary outcome measures will be the time and number of attempts to achieve the correct depth and participant satisfaction.

Read the detailed description

Although less invasive surfactant administration (LISA) offers some advantages in ventilation procedure and neonatal outcomes, achieving the correct depth in the trachea using a LISA catheter may be difficult. This may have some drawbacks such as impaired surfactant administration (reducing the efficacy of the procedure) or prolonged duration of the laryngoscopy (aggravating the invasiveness of the procedure).

The aims of the present study should be: i) positioning of the device at the correct depth in the trachea, ii) time and number of attempts to achieve the correct depth, iii) participant satisfaction.

This is an unblinded, randomized, controlled, crossover (AB/BA) trial of surfactant treatment with LISA catheter with a marked tip vs. LISA catheter with an unmarked tip in a manikin simulating an extremely low birth weight infant. Participants will be level III NICU consultants and residents. Randomization will be performed using a computer-generated random assignment list. The primary outcome measure will be the positioning of the device at the correct depth in the trachea. The secondary outcome measures will be the time and number of attempts to achieve the correct depth and participant satisfaction.

02

Conditions studied

03

In context

Respiratory Distress Syndrome

1,597 studies on the registry are indexed under Respiratory Distress Syndrome; 312 are open to participants now.

This study's enrollment of 50 is below the median of 60 across 961 interventional studies indexed under Respiratory Distress Syndrome.

Browse Respiratory Distress Syndrome studies →

Lead sponsor

University Hospital Padova is the lead sponsor of 41 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Level III NICU consultants and residents will be eligible to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Refusal to participate in the study.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    Surfactant administration with less invasive surfactant administration (LISA) marked tip catheter

    Participants will be assigned to perform the procedure with a LISA catheter with a marked tip

    Device: Surfactant administration with less invasive surfactant administration (LISA) marked tip catheter

  • Active comparator
    Surfactant administration with less invasive surfactant administration (LISA) unmarked tip catheter

    Participants will be assigned to perform the procedure with a LISA catheter with an unmarked tip

    Device: Surfactant administration with less invasive surfactant administration (LISA) unmarked tip catheter

Interventions

  • DeviceSurfactant administration with less invasive surfactant administration (LISA) marked tip catheter

    Participants will be assigned to perform the procedure with LISA catheter with a marked tip

  • DeviceSurfactant administration with less invasive surfactant administration (LISA) unmarked tip catheter

    Participants will be assigned to perform the procedure with LISA catheter with an unmarked tip

06

What researchers measure

Primary outcomes

  1. Number of participants who will achieve the positioning of the device at the correct depth in the trachea

    Number of participants who will achieve the positioning of the device at the correct depth in the trachea (as assessed by the external observer using a laryngoscope).

    Time frame: 5 minutes

Secondary outcomes

  1. Time for positioning the device in the trachea

    The time of device positioning will be defined as the time elapsed from the positioning of the laryngoscope in the manikin mouth to the connection of the syringe to the catheter

    Time frame: 5 minutes

  2. Number of attempts for positioning the device in the trachea

    The total number of attempts for positioning the device in the trachea

    Time frame: 5 minutes

  3. Participant opinion on using the device

    Participant opinion on using the device which will be evaluated using a Likert scale (1 worse outcome to 5 best outcome)

    Time frame: 10 minutes

07

Study locations

1 site
  • Daniele Trevisanuto
    Padova, 35128, Italy
08

References and documents

Publications

  • Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Te Pas A, Plavka R, Roehr CC, Saugstad OD, Simeoni U, Speer CP, Vento M, Visser GHA, Halliday HL. European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2019 Update. Neonatology. 2019;115(4):432-450. doi: 10.1159/000499361. Epub 2019 Apr 11. PubMed 30974433 ↗

Individual participant data

Plan to share: Yes — The data will be available upon motivated request to the corresponding author

Supporting information: Study protocol, Sap, Csr

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 26, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05399628
Lead sponsor
University Hospital Padova
Responsible party
Daniele Trevisanuto (Associate Professor, University Hospital Padova) — Principal investigator
First posted
Jun 1, 2022
Start date
Jun 6, 2022
Primary completion
Jun 11, 2022
Completion
Jun 11, 2022
Last update
Jul 26, 2022

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion